Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PET imaging in patients with meningioma-report of the RANO/PET Group.
Galldiks N, Albert NL, Sommerauer M, Grosu AL, Ganswindt U, Law I, Preusser M, Le Rhun E, Vogelbaum MA, Zadeh G, Dhermain F, Weller M, Langen KJ, Tonn JC. Galldiks N, et al. Among authors: ganswindt u. Neuro Oncol. 2017 Nov 29;19(12):1576-1587. doi: 10.1093/neuonc/nox112. Neuro Oncol. 2017. PMID: 28605532 Free PMC article. Review.
[68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.
Gehler B, Paulsen F, Oksüz MO, Hauser TK, Eschmann SM, Bares R, Pfannenberg C, Bamberg M, Bartenstein P, Belka C, Ganswindt U. Gehler B, et al. Among authors: ganswindt u. Radiat Oncol. 2009 Nov 18;4:56. doi: 10.1186/1748-717X-4-56. Radiat Oncol. 2009. PMID: 19922642 Free PMC article.
FET-PET for malignant glioma treatment planning.
Niyazi M, Geisler J, Siefert A, Schwarz SB, Ganswindt U, Garny S, Schnell O, Suchorska B, Kreth FW, Tonn JC, Bartenstein P, la Fougère C, Belka C. Niyazi M, et al. Among authors: ganswindt u. Radiother Oncol. 2011 Apr;99(1):44-8. doi: 10.1016/j.radonc.2011.03.001. Epub 2011 Mar 30. Radiother Oncol. 2011. PMID: 21458093
FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status.
Niyazi M, Schnell O, Suchorska B, Schwarz SB, Ganswindt U, Geisler J, Bartenstein P, Kreth FW, Tonn JC, Eigenbrod S, Belka C, la Fougère C. Niyazi M, et al. Among authors: ganswindt u. Radiother Oncol. 2012 Jul;104(1):78-82. doi: 10.1016/j.radonc.2012.04.022. Epub 2012 Jun 5. Radiother Oncol. 2012. PMID: 22673727
Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.
Niyazi M, Jansen N, Ganswindt U, Schwarz SB, Geisler J, Schnell O, Büsing K, Eigenbrod S, la Fougère C, Belka C. Niyazi M, et al. Among authors: ganswindt u. J Neurooncol. 2012 Dec;110(3):389-95. doi: 10.1007/s11060-012-0980-7. Epub 2012 Oct 4. J Neurooncol. 2012. PMID: 23054562
Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis.
Schanne DH, Nestle U, Allgäuer M, Andratschke N, Appold S, Dieckmann U, Ernst I, Ganswindt U, Grosu AL, Holy R, Molls M, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Guckenberger M. Schanne DH, et al. Among authors: ganswindt u. Strahlenther Onkol. 2015 Feb;191(2):125-32. doi: 10.1007/s00066-014-0739-5. Epub 2014 Aug 27. Strahlenther Onkol. 2015. PMID: 25159135
178 results